DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

00874 BAIYUNSHAN PH

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Guangzhou Pharmaceutical Holdings Limited (45.04%) Sector Health Care & Biotechnology
Web Site http://www.gybys.com.cn Tel (86 20) 6628-1011
Email sec@gybys.com.cn Fax (86 20) 6628-1229
Related Equities N/A
Principal Activities The Group is principally engaged in: (1) the research and development, manufacturing and sales of Chinese patent medicine, Western medicine, chemical raw materials, natural medicine, biological medicine and chemical raw materials intermediates; (2) the wholesale, retail and import and export business of Western medicine, Chinese medicine and medical equipment; (3) the research and development, production and sales of great health product; and (4) the health industry investment in medical care, health management, health maintenance and elderly care, etc.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Norges Bank 24,948,000(L)  11.35(L)  01/11/2018
Citigroup Inc. 21,919,106(L) 438,000(S) 21,331,106(P)  9.96(L) 0.19(S) 9.70(P)  07/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top